000 01128 a2200289 4500
005 20250518081035.0
264 0 _c20210628
008 202106s 0 0 eng d
022 _a1764-1489
024 7 _a10.23822/EurAnnACI.1764-1489.120
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRodrigues, M A
245 0 0 _aThe Changing Landscape of Atopic Dermatitis - Focusing on JAK Inhibitors.
_h[electronic resource]
260 _bEuropean annals of allergy and clinical immunology
_c01 2020
300 _a45-48 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAnti-Allergic Agents
_xtherapeutic use
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aAnti-Inflammatory Agents
_xtherapeutic use
650 0 4 _aDermatitis, Atopic
_xtherapy
650 0 4 _aEmollients
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aJanus Kinase Inhibitors
_xtherapeutic use
700 1 _aTorres, T
773 0 _tEuropean annals of allergy and clinical immunology
_gvol. 52
_gno. 1
_gp. 45-48
856 4 0 _uhttps://doi.org/10.23822/EurAnnACI.1764-1489.120
_zAvailable from publisher's website
999 _c30514431
_d30514431